25 XP   0   0   10

Isofol Medical AB
Buy, Hold or Sell?

Let's analyse Isofol Medical AB together

PenkeI guess you are interested in Isofol Medical AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Isofol Medical AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Isofol Medical AB

I send you an email if I find something interesting about Isofol Medical AB.

Quick analysis of Isofol Medical AB (30 sec.)










What can you expect buying and holding a share of Isofol Medical AB? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.75
Expected worth in 1 year
kr0.52
How sure are you?
16.1%

+ What do you gain per year?

Total Gains per Share
kr-0.23
Return On Investment
-31.9%

For what price can you sell your share?

Current Price per Share
kr0.72
Expected price per share
kr0.56 - kr1.08
How sure are you?
50%

1. Valuation of Isofol Medical AB (5 min.)




Live pricePrice per Share (EOD)

kr0.72

Intrinsic Value Per Share

kr1.39 - kr2.06

Total Value Per Share

kr2.14 - kr2.81

2. Growth of Isofol Medical AB (5 min.)




Is Isofol Medical AB growing?

Current yearPrevious yearGrowGrow %
How rich?$11.1m$19m-$6.8m-55.7%

How much money is Isofol Medical AB making?

Current yearPrevious yearGrowGrow %
Making money-$851k-$3.4m$2.6m306.0%
Net Profit Margin155,481.1%-1,188.6%--

How much money comes from the company's main activities?

3. Financial Health of Isofol Medical AB (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#662 / 1010

Most Revenue
#680 / 1010

Most Profit
#229 / 1010

What can you expect buying and holding a share of Isofol Medical AB? (5 min.)

Welcome investor! Isofol Medical AB's management wants to use your money to grow the business. In return you get a share of Isofol Medical AB.

What can you expect buying and holding a share of Isofol Medical AB?

First you should know what it really means to hold a share of Isofol Medical AB. And how you can make/lose money.

Speculation

The Price per Share of Isofol Medical AB is kr0.718. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Isofol Medical AB.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Isofol Medical AB, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.75. Based on the TTM, the Book Value Change Per Share is kr-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Isofol Medical AB.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.01-0.7%-0.01-0.7%-0.02-3.2%-0.02-3.0%-0.02-2.4%
Usd Book Value Change Per Share-0.01-0.7%-0.01-0.7%-0.02-3.2%0.00-0.6%0.000.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-0.7%-0.01-0.7%-0.02-3.2%0.00-0.6%0.000.3%
Usd Price Per Share0.07-0.06-0.43-0.99-1.13-
Price to Earnings Ratio-3.32--3.31--3.94--11.13--18.49-
Price-to-Total Gains Ratio-13.27--13.24--15.76--41.64--74.62-
Price to Book Ratio0.97-0.83-3.20-18.28-14.48-
Price-to-Total Gains Ratio-13.27--13.24--15.76--41.64--74.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0659842
Number of shares15155
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (15155 shares)-79.86-61.90
Gains per Year (15155 shares)-319.44-247.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-319-3290-248-258
20-639-6480-495-506
30-958-9670-743-754
40-1278-12860-990-1002
50-1597-16050-1238-1250
60-1917-19240-1486-1498
70-2236-22430-1733-1746
80-2556-25620-1981-1994
90-2875-28810-2228-2242
100-3194-32000-2476-2490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.031.00.00.0%0.031.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%5.024.02.016.1%5.024.02.016.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.031.00.0%0.00.031.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%5.024.02.016.1%5.024.02.016.1%

Fundamentals of Isofol Medical AB

About Isofol Medical AB

Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.

Fundamental data was last updated by Penke on 2024-04-22 12:38:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Isofol Medical AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Isofol Medical AB earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Isofol Medical AB to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Isofol Medical AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM155,481.1%-155,481.1%
TTM155,481.1%YOY-1,188.6%+156,669.7%
TTM155,481.1%5Y30,649.3%+124,831.7%
5Y30,649.3%10Y19,213.7%+11,435.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM155,481.1%-216.8%+155,697.9%
YOY-1,188.6%-282.3%-906.3%
5Y30,649.3%-436.8%+31,086.1%
10Y19,213.7%-597.3%+19,811.0%
1.1.2. Return on Assets

Shows how efficient Isofol Medical AB is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Isofol Medical AB to the Biotechnology industry mean.
  • -6.3% Return on Assets means that Isofol Medical AB generated kr-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Isofol Medical AB:

  • The MRQ is -6.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-5.9%-0.4%
TTM-5.9%YOY-13.3%+7.4%
TTM-5.9%5Y-18.5%+12.7%
5Y-18.5%10Y-25.8%+7.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.3%-13.3%+7.0%
TTM-5.9%-12.8%+6.9%
YOY-13.3%-11.6%-1.7%
5Y-18.5%-13.8%-4.7%
10Y-25.8%-15.6%-10.2%
1.1.3. Return on Equity

Shows how efficient Isofol Medical AB is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Isofol Medical AB to the Biotechnology industry mean.
  • -7.3% Return on Equity means Isofol Medical AB generated kr-0.07 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Isofol Medical AB:

  • The MRQ is -7.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -6.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.3%TTM-6.9%-0.4%
TTM-6.9%YOY-18.0%+11.1%
TTM-6.9%5Y-34.2%+27.3%
5Y-34.2%10Y-93.6%+59.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.3%-16.9%+9.6%
TTM-6.9%-16.1%+9.2%
YOY-18.0%-14.9%-3.1%
5Y-34.2%-19.3%-14.9%
10Y-93.6%-20.1%-73.5%

1.2. Operating Efficiency of Isofol Medical AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Isofol Medical AB is operating .

  • Measures how much profit Isofol Medical AB makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Isofol Medical AB to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Isofol Medical AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM155,481.4%-155,481.4%
TTM155,481.4%YOY-1,311.1%+156,792.5%
TTM155,481.4%5Y30,625.0%+124,856.4%
5Y30,625.0%10Y19,185.9%+11,439.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM155,481.4%-238.5%+155,719.9%
YOY-1,311.1%-288.4%-1,022.7%
5Y30,625.0%-486.2%+31,111.2%
10Y19,185.9%-628.4%+19,814.3%
1.2.2. Operating Ratio

Measures how efficient Isofol Medical AB is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Isofol Medical AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1,896.199+1,896.199
TTM-1,896.199YOY27.695-1,923.894
TTM-1,896.1995Y-370.177-1,526.022
5Y-370.17710Y-233.191-136.987
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM-1,896.1993.310-1,899.509
YOY27.6953.838+23.857
5Y-370.1775.679-375.856
10Y-233.1917.823-241.014

1.3. Liquidity of Isofol Medical AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Isofol Medical AB is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.70 means the company has kr7.70 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Isofol Medical AB:

  • The MRQ is 7.703. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.143. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.703TTM7.143+0.560
TTM7.143YOY3.891+3.252
TTM7.1435Y4.813+2.330
5Y4.81310Y9.385-4.572
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7033.863+3.840
TTM7.1434.169+2.974
YOY3.8915.337-1.446
5Y4.8136.122-1.309
10Y9.3856.434+2.951
1.3.2. Quick Ratio

Measures if Isofol Medical AB is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Isofol Medical AB to the Biotechnology industry mean.
  • A Quick Ratio of 7.69 means the company can pay off kr7.69 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Isofol Medical AB:

  • The MRQ is 7.686. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.572. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.686TTM10.572-2.886
TTM10.572YOY3.296+7.275
TTM10.5725Y5.289+5.283
5Y5.28910Y10.432-5.143
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.6863.504+4.182
TTM10.5723.991+6.581
YOY3.2965.371-2.075
5Y5.2896.088-0.799
10Y10.4326.395+4.037

1.4. Solvency of Isofol Medical AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Isofol Medical AB assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Isofol Medical AB to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14 means that Isofol Medical AB assets are financed with 13.6% credit (debt) and the remaining percentage (100% - 13.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Isofol Medical AB:

  • The MRQ is 0.136. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.147. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.136TTM0.147-0.010
TTM0.147YOY0.261-0.114
TTM0.1475Y0.271-0.125
5Y0.27110Y0.288-0.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1360.339-0.203
TTM0.1470.337-0.190
YOY0.2610.271-0.010
5Y0.2710.368-0.097
10Y0.2880.388-0.100
1.4.2. Debt to Equity Ratio

Measures if Isofol Medical AB is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Isofol Medical AB to the Biotechnology industry mean.
  • A Debt to Equity ratio of 15.8% means that company has kr0.16 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Isofol Medical AB:

  • The MRQ is 0.158. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.172. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.158TTM0.172-0.014
TTM0.172YOY0.354-0.182
TTM0.1725Y0.517-0.344
5Y0.51710Y0.934-0.417
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1580.392-0.234
TTM0.1720.403-0.231
YOY0.3540.335+0.019
5Y0.5170.427+0.090
10Y0.9340.461+0.473

2. Market Valuation of Isofol Medical AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Isofol Medical AB generates.

  • Above 15 is considered overpriced but always compare Isofol Medical AB to the Biotechnology industry mean.
  • A PE ratio of -3.32 means the investor is paying kr-3.32 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Isofol Medical AB:

  • The EOD is -3.264. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.318. Based on the earnings, the company is expensive. -2
  • The TTM is -3.309. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.264MRQ-3.318+0.055
MRQ-3.318TTM-3.309-0.009
TTM-3.309YOY-3.940+0.631
TTM-3.3095Y-11.127+7.818
5Y-11.12710Y-18.495+7.368
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.264-2.300-0.964
MRQ-3.318-2.656-0.662
TTM-3.309-2.718-0.591
YOY-3.940-4.145+0.205
5Y-11.127-6.258-4.869
10Y-18.495-6.315-12.180
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Isofol Medical AB:

  • The EOD is -4.119. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.188. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.726. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.119MRQ-4.188+0.069
MRQ-4.188TTM-2.726-1.462
TTM-2.726YOY-3.692+0.967
TTM-2.7265Y-11.982+9.256
5Y-11.98210Y-19.577+7.595
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.119-2.974-1.145
MRQ-4.188-3.306-0.882
TTM-2.726-3.508+0.782
YOY-3.692-5.613+1.921
5Y-11.982-8.378-3.604
10Y-19.577-8.873-10.704
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Isofol Medical AB is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.97 means the investor is paying kr0.97 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Isofol Medical AB:

  • The EOD is 0.955. Based on the equity, the company is cheap. +2
  • The MRQ is 0.971. Based on the equity, the company is cheap. +2
  • The TTM is 0.827. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.955MRQ0.971-0.016
MRQ0.971TTM0.827+0.144
TTM0.827YOY3.201-2.373
TTM0.8275Y18.279-17.452
5Y18.27910Y14.480+3.800
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.9551.914-0.959
MRQ0.9712.116-1.145
TTM0.8272.097-1.270
YOY3.2012.881+0.320
5Y18.2793.550+14.729
10Y14.4803.936+10.544
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Isofol Medical AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.055-0.057+4%-0.247+350%-0.044-19%0.024-327%
Book Value Per Share--0.7520.824-9%1.283-41%1.119-33%1.184-36%
Current Ratio--7.7037.143+8%3.891+98%4.813+60%9.385-18%
Debt To Asset Ratio--0.1360.147-7%0.261-48%0.271-50%0.288-53%
Debt To Equity Ratio--0.1580.172-8%0.354-55%0.517-69%0.934-83%
Dividend Per Share----0%-0%-0%-0%
Eps---0.055-0.057+4%-0.247+350%-0.231+321%-0.190+246%
Free Cash Flow Per Share---0.044-0.081+87%-0.296+578%-0.232+432%-0.190+336%
Free Cash Flow To Equity Per Share---0.038-0.081+115%-0.298+689%-0.046+22%-0.064+68%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.062--------
Intrinsic Value_10Y_min--1.386--------
Intrinsic Value_1Y_max---0.734--------
Intrinsic Value_1Y_min---0.721--------
Intrinsic Value_3Y_max---1.487--------
Intrinsic Value_3Y_min---1.434--------
Intrinsic Value_5Y_max---1.377--------
Intrinsic Value_5Y_min---1.340--------
Market Cap115967775.744-2%117906271.200108942164.280+8%751046796.000-84%1746769519.008-93%1990792861.502-94%
Net Profit Margin---1554.811-100%-11.8860%306.493-100%192.137-100%
Operating Margin---1554.814-100%-13.1110%306.250-100%191.859-100%
Operating Ratio----1896.1990%27.695-100%-370.1770%-233.1910%
Pb Ratio0.955-2%0.9710.827+17%3.201-70%18.279-95%14.480-93%
Pe Ratio-3.264+2%-3.318-3.3090%-3.940+19%-11.127+235%-18.495+457%
Price Per Share0.718-2%0.7300.675+8%4.650-84%10.815-93%12.326-94%
Price To Free Cash Flow Ratio-4.119+2%-4.188-2.726-35%-3.692-12%-11.982+186%-19.577+367%
Price To Total Gains Ratio-13.055+2%-13.273-13.2360%-15.761+19%-41.637+214%-74.622+462%
Quick Ratio--7.68610.572-27%3.296+133%5.289+45%10.432-26%
Return On Assets---0.063-0.059-7%-0.133+110%-0.185+193%-0.258+309%
Return On Equity---0.073-0.069-6%-0.180+146%-0.342+367%-0.936+1179%
Total Gains Per Share---0.055-0.057+4%-0.247+350%-0.044-19%0.024-327%
Usd Book Value--11159692.70012232073.800-9%19045769.550-41%16605456.950-33%17571564.594-36%
Usd Book Value Change Per Share---0.005-0.005+4%-0.023+350%-0.004-19%0.002-327%
Usd Book Value Per Share--0.0690.076-9%0.118-41%0.103-33%0.109-36%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.005-0.005+4%-0.023+350%-0.021+321%-0.017+246%
Usd Free Cash Flow---646792.200-1207037.575+87%-4387627.650+578%-3437730.870+432%-2818842.771+336%
Usd Free Cash Flow Per Share---0.004-0.007+87%-0.027+578%-0.021+432%-0.017+336%
Usd Free Cash Flow To Equity Per Share---0.003-0.007+115%-0.027+689%-0.004+22%-0.006+68%
Usd Market Cap10657438.591-2%10835586.32310011784.897+8%69021200.552-84%160528118.797-93%182953863.972-94%
Usd Price Per Share0.066-2%0.0670.062+8%0.427-84%0.994-93%1.133-94%
Usd Profit---816347.700-851062.925+4%-3454957.525+323%-3392263.345+316%-2795648.397+242%
Usd Revenue---24835.975-100%293988.100-100%337286.785-100%217829.681-100%
Usd Total Gains Per Share---0.005-0.005+4%-0.023+350%-0.004-19%0.002-327%
 EOD+3 -5MRQTTM+20 -12YOY+23 -85Y+17 -1510Y+15 -17

3.2. Fundamental Score

Let's check the fundamental score of Isofol Medical AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.264
Price to Book Ratio (EOD)Between0-10.955
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than17.686
Current Ratio (MRQ)Greater than17.703
Debt to Asset Ratio (MRQ)Less than10.136
Debt to Equity Ratio (MRQ)Less than10.158
Return on Equity (MRQ)Greater than0.15-0.073
Return on Assets (MRQ)Greater than0.05-0.063
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Isofol Medical AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.447
Ma 20Greater thanMa 500.728
Ma 50Greater thanMa 1000.674
Ma 100Greater thanMa 2000.663
OpenGreater thanClose0.692
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Reconciled Depreciation  421-17404-57347-237110-933-823



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets140,597
Total Liabilities19,164
Total Stockholder Equity121,433
 As reported
Total Liabilities 19,164
Total Stockholder Equity+ 121,433
Total Assets = 140,597

Assets

Total Assets140,597
Total Current Assets140,594
Long-term Assets3
Total Current Assets
Cash And Cash Equivalents 138,148
Net Receivables 2,145
Other Current Assets 301
Total Current Assets  (as reported)140,594
Total Current Assets  (calculated)140,594
+/-0
Long-term Assets
Property Plant Equipment 3
Long-term Assets  (as reported)3
Long-term Assets  (calculated)3
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities18,253
Long-term Liabilities911
Total Stockholder Equity121,433
Total Current Liabilities
Accounts payable 1,988
Other Current Liabilities 16,265
Total Current Liabilities  (as reported)18,253
Total Current Liabilities  (calculated)18,253
+/-0
Long-term Liabilities
Long-term Liabilities Other 2
Long-term Liabilities  (as reported)911
Long-term Liabilities  (calculated)2
+/- 909
Total Stockholder Equity
Common Stock4,945
Retained Earnings -1,101,789
Accumulated Other Comprehensive Income 1
Other Stockholders Equity 1,218,276
Total Stockholder Equity (as reported)121,433
Total Stockholder Equity (calculated)121,433
+/-0
Other
Capital Stock4,945
Cash and Short Term Investments 138,148
Common Stock Shares Outstanding 161,515
Liabilities and Stockholders Equity 140,597
Net Debt -138,148
Net Invested Capital 121,432
Net Working Capital 122,341
Property Plant and Equipment Gross 70



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-12-31
> Total Assets 
9,777
0
0
22,890
0
398,741
377,445
361,276
345,055
321,699
305,037
288,552
268,388
239,218
207,746
146,470
95,042
209,866
187,600
148,130
105,431
559,787
453,923
401,363
350,566
298,562
256,059
213,464
172,095
161,831
150,133
140,597
140,597150,133161,831172,095213,464256,059298,562350,566401,363453,923559,787105,431148,130187,600209,86695,042146,470207,746239,218268,388288,552305,037321,699345,055361,276377,445398,741022,890009,777
   > Total Current Assets 
9,156
0
0
22,327
0
398,176
376,917
360,795
344,613
321,295
304,673
284,460
259,263
230,107
198,896
137,019
85,447
200,627
178,747
139,841
97,559
552,319
446,771
394,609
345,245
295,411
254,921
209,451
171,322
161,646
150,109
140,594
140,594150,109161,646171,322209,451254,921295,411345,245394,609446,771552,31997,559139,841178,747200,62785,447137,019198,896230,107259,263284,460304,673321,295344,613360,795376,917398,176022,327009,156
       Cash And Cash Equivalents 
7,294
0
0
19,114
0
392,236
23,309
357,331
341,108
244,982
222,952
272,898
245,823
222,071
190,433
126,983
72,491
185,709
153,612
116,393
77,524
530,682
348,223
379,448
311,799
251,514
162,345
190,583
163,963
156,767
144,226
138,148
138,148144,226156,767163,963190,583162,345251,514311,799379,448348,223530,68277,524116,393153,612185,70972,491126,983190,433222,071245,823272,898222,952244,982341,108357,33123,309392,236019,114007,294
       Short-term Investments 
0
0
0
0
0
0
350,650
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
381,166
0
0
0
000381,166000000000000000000000350,650000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
8,036
8,463
4,159
12,956
14,917
25,136
18,379
20,035
21,637
25,910
7,196
10,108
1,626
850
4,363
6,661
2,288
2,594
2,145
2,1452,5942,2886,6614,3638501,62610,1087,19625,91021,63720,03518,37925,13614,91712,9564,1598,4638,0360000000000000
       Other Current Assets 
1,862
0
0
3,213
0
5,940
2,958
3,464
3,505
76,313
81,721
-1
13,440
8,036
8,463
-1
12,956
1
-1
23,448
20,035
21,637
98,548
1
13,210
43,897
19,088
1
698
2,591
1
301
30112,591698119,08843,89713,210198,54821,63720,03523,448-1112,956-18,4638,03613,440-181,72176,3133,5053,4642,9585,94003,213001,862
   > Long-term Assets 
621
0
0
563
0
565
528
481
442
404
364
4,092
9,125
9,111
8,850
9,451
9,595
9,239
8,853
8,289
7,872
7,468
7,152
6,755
5,321
3,151
1,139
4,013
773
185
24
3
3241857734,0131,1393,1515,3216,7557,1527,4687,8728,2898,8539,2399,5959,4518,8509,1119,1254,092364404442481528565056300621
       Property Plant Equipment 
130
0
0
171
0
223
211
189
175
161
146
132
4,605
4,640
4,404
4,434
4,397
4,099
3,771
3,258
2,858
2,459
2,143
1,746
1,640
1,241
1,139
4,014
773
185
24
3
3241857734,0141,1391,2411,6401,7462,1432,4592,8583,2583,7714,0994,3974,4344,4044,6404,605132146161175189211223017100130
       Intangible Assets 
491
0
0
392
0
342
317
292
267
243
218
192
168
143
118
94
69
44
19
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000019446994118143168192218243267292317342039200491
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
4,328
4,328
4,923
5,129
5,096
5,063
5,031
5,014
5,009
5,009
-1
3,681
1,910
-1
0
0
0
0
0
00000-11,9103,681-15,0095,0095,0145,0315,0635,0965,1294,9234,3284,3280000000000000
> Total Liabilities 
8,455
0
0
16,791
0
10,328
8,792
18,243
16,809
10,402
11,043
23,544
28,863
34,445
44,924
41,562
46,074
58,601
66,374
81,563
81,526
128,958
74,520
83,130
80,206
82,236
72,245
54,986
28,012
25,255
19,817
19,164
19,16419,81725,25528,01254,98672,24582,23680,20683,13074,520128,95881,52681,56366,37458,60146,07441,56244,92434,44528,86323,54411,04310,40216,80918,2438,79210,328016,791008,455
   > Total Current Liabilities 
8,455
0
0
16,791
0
10,328
8,792
18,243
16,809
10,402
11,043
23,544
25,546
31,304
42,111
38,801
43,446
56,245
64,350
80,124
80,365
128,190
74,098
83,020
79,876
81,967
71,000
51,735
27,154
24,359
18,943
18,253
18,25318,94324,35927,15451,73571,00081,96779,87683,02074,098128,19080,36580,12464,35056,24543,44638,80142,11131,30425,54623,54411,04310,40216,80918,2438,79210,328016,791008,455
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,677
0
0
1,623
1,542
0
0
0
1,543
0
0
0
0
00001,5430001,5421,623001,6770000000000000000000
       Accounts payable 
5,408
0
0
12,406
0
0
0
9,327
0
0
0
12,353
0
0
0
10,247
0
0
0
20,889
0
0
0
17,736
16,577
8,725
16,594
7,520
2,898
1,988
2,574
1,988
1,9882,5741,9882,8987,52016,5948,72516,57717,73600020,88900010,24700012,3530009,32700012,406005,408
       Other Current Liabilities 
3,047
0
0
4,385
0
10,328
8,792
8,916
16,809
10,402
11,043
11,191
25,546
31,304
42,111
28,554
43,446
56,245
64,350
1,873
80,365
128,190
72,475
-1
63,299
73,242
54,406
42,672
24,256
22,371
16,369
16,265
16,26516,36922,37124,25642,67254,40673,24263,299-172,475128,19080,3651,87364,35056,24543,44628,55442,11131,30425,54611,19111,04310,40216,8098,9168,79210,32804,385003,047
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
3,317
3,141
2,813
2,761
2,628
2,356
2,024
1,439
1,161
768
422
110
330
269
1,245
3,251
858
896
874
911
9118748968583,2511,2452693301104227681,1611,4392,0242,3562,6282,7612,8133,1413,317000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,025
1,439
1,160
769
422
110
330
269
417
2,405
1
0
0
0
00012,4054172693301104227691,1601,4392,025000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
1
-1
0
0
0
0
828
845
0
895
0
0
0089508458280000-110-1000000000000000000
> Total Stockholder Equity
1,322
0
0
6,099
0
388,413
368,653
343,033
328,246
311,297
293,994
265,008
239,525
204,773
162,822
104,908
48,968
151,265
121,226
66,567
23,905
430,829
379,403
318,233
270,360
216,326
183,814
158,478
144,083
136,576
130,316
121,433
121,433130,316136,576144,083158,478183,814216,326270,360318,233379,403430,82923,90566,567121,226151,26548,968104,908162,822204,773239,525265,008293,994311,297328,246343,033368,653388,41306,099001,322
   Common Stock
273
0
0
322
0
0
0
968
0
0
0
981
981
981
981
981
981
2,552
2,552
2,552
2,552
4,945
4,945
4,945
4,945
4,945
4,945
4,945
4,945
4,945
4,945
4,945
4,9454,9454,9454,9454,9454,9454,9454,9454,9454,9454,9452,5522,5522,5522,55298198198198198198100096800032200273
   Retained Earnings -1,101,789-1,092,236-1,085,976-1,078,469-1,064,074-1,038,739-1,006,226-952,193-904,320-843,149-792,123-746,730-704,069-649,409-619,310-570,991-515,076-457,162-415,211-380,459-353,493000-267,814000-195,52500-131,507
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
619,003
618,978
768,023
768,083
768,083
768,083
1,218,007
1,217,607
1,217,607
1,217,607
1,217,607
1,217,607
1,217,607
1,217,607
1,217,607
0
0
001,217,6071,217,6071,217,6071,217,6071,217,6071,217,6071,217,6071,217,6071,218,007768,083768,083768,083768,023618,978619,003000000000000000
   Treasury Stock00000000000000000000000000000000
   Other Stockholders Equity 
132,556
0
0
201,302
0
388,413
368,653
609,879
328,246
311,297
293,994
617,520
619,003
619,003
619,003
619,003
618,978
768,023
768,083
768,084
768,083
1,218,007
1,217,607
1,217,608
1,217,608
1,217,607
1,217,607
1,217,606
1,059,128
1,217,606
1,217,606
1,218,276
1,218,2761,217,6061,217,6061,059,1281,217,6061,217,6071,217,6071,217,6081,217,6081,217,6071,218,007768,083768,084768,083768,023618,978619,003619,003619,003619,003617,520293,994311,297328,246609,879368,653388,4130201,30200132,556



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue721
Cost of Revenue-42,597
Gross Profit-41,876-41,876
 
Operating Income (+$)
Gross Profit-41,876
Operating Expense-42,405
Operating Income-41,876-84,281
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense42,4050
 
Net Interest Income (+$)
Interest Income3,985
Interest Expense-10
Other Finance Cost-8,013
Net Interest Income-4,038
 
Pretax Income (+$)
Operating Income-41,876
Net Interest Income-4,038
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-37,071-46,681
EBIT - interestExpense = -41,886
-37,071
-37,061
Interest Expense10
Earnings Before Interest and Taxes (EBIT)-41,876-37,061
Earnings Before Interest and Taxes (EBITDA)-41,839
 
After tax Income (+$)
Income Before Tax-37,071
Tax Provision-0
Net Income From Continuing Ops-53,497-37,071
Net Income-37,071
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses42,597
Total Other Income/Expenses Net4,8054,038
 

Technical Analysis of Isofol Medical AB
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Isofol Medical AB. The general trend of Isofol Medical AB is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Isofol Medical AB's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Isofol Medical AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.072 < 1.08 < 1.08.

The bearish price targets are: 0.636 > 0.618 > 0.56.

Tweet this
Isofol Medical AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Isofol Medical AB. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Isofol Medical AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Isofol Medical AB. The current macd is 0.00438809.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Isofol Medical AB price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Isofol Medical AB. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Isofol Medical AB price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Isofol Medical AB Daily Moving Average Convergence/Divergence (MACD) ChartIsofol Medical AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Isofol Medical AB. The current adx is 49.60.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Isofol Medical AB shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Isofol Medical AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Isofol Medical AB. The current sar is 0.66984748.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Isofol Medical AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Isofol Medical AB. The current rsi is 51.45. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Isofol Medical AB Daily Relative Strength Index (RSI) ChartIsofol Medical AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Isofol Medical AB. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Isofol Medical AB price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Isofol Medical AB Daily Stochastic Oscillator ChartIsofol Medical AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Isofol Medical AB. The current cci is -52.27460711.

Isofol Medical AB Daily Commodity Channel Index (CCI) ChartIsofol Medical AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Isofol Medical AB. The current cmo is 2.21577394.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Isofol Medical AB Daily Chande Momentum Oscillator (CMO) ChartIsofol Medical AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Isofol Medical AB. The current willr is -81.19266055.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Isofol Medical AB Daily Williams %R ChartIsofol Medical AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Isofol Medical AB.

Isofol Medical AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Isofol Medical AB. The current atr is 0.08884368.

Isofol Medical AB Daily Average True Range (ATR) ChartIsofol Medical AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Isofol Medical AB. The current obv is -16,877,949.

Isofol Medical AB Daily On-Balance Volume (OBV) ChartIsofol Medical AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Isofol Medical AB. The current mfi is 79.79.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Isofol Medical AB Daily Money Flow Index (MFI) ChartIsofol Medical AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Isofol Medical AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-24MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Isofol Medical AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Isofol Medical AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.447
Ma 20Greater thanMa 500.728
Ma 50Greater thanMa 1000.674
Ma 100Greater thanMa 2000.663
OpenGreater thanClose0.692
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Isofol Medical AB with someone you think should read this too:
  • Are you bullish or bearish on Isofol Medical AB? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Isofol Medical AB? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Isofol Medical AB

I send you an email if I find something interesting about Isofol Medical AB.


Comments

How you think about this?

Leave a comment

Stay informed about Isofol Medical AB.

Receive notifications about Isofol Medical AB in your mailbox!